Skip to content
Screener

Arrowhead Research ARWR Accounts Receivable

Accounts Receivable at other companies

ALN
Alnylam PharmaceuticalsALNY
$912.74M+60.9%
Assembly Biosciences logo
Assembly BiosciencesASMB
$451K
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$178.74M+15,022%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$200M+60.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$205.23M+78.0%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$34.19M+91.8%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Current assets:
Cash, cash equivalents and restricted cash$147,531$88,706
Cash at variable interest entity40,986137,842
Accounts receivable15,6856,824
Available-for-sale securities, at fair value and short-term investments1,595,574692,818
Prepaid expenses21,72110,933
Other current assets18,25413,516
Total current assets1,839,751950,639

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's accounts receivable?
Arrowhead Research (ARWR) reported accounts receivable of $15.69M in Q1 2026.
How has Arrowhead Research's accounts receivable changed year-over-year?
Arrowhead Research's accounts receivable increased by 563.2% year-over-year, from $2.37M to $15.69M.
What is the long-term trend for Arrowhead Research's accounts receivable?
Over 4 years (2021 to 2025), Arrowhead Research's accounts receivable has grown at a -9.7% compound annual growth rate (CAGR), from $10.26M to $6.82M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.

Ask your AI about Arrowhead Research's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude